New research from CHEOS Scientists and St. Paul’s clinicians explores how health provider and inpatient service users feel about sensory modulation rooms, and how their use can empower patients and help reduce the use of more invasive means of control.
Category Archives: Press Release
Canada is the first country to approve the pain drug for severe opioid use disorder, a result of research led by CHÉOS and PHC scientists and staff.
The study, co-authored by CHÉOS’ Dr. John Staples, found a 43-per-cent increase in the risk of pedestrian death on Halloween compared to control days one week earlier and one week later.
Most fentanyl overdose survivors, if given the antidote promptly, don’t need prolonged hospital treatment, according to a study by University of British Columbia physicians.
The results of the SALOME trial show chronic heroin addiction now has another effective treatment tool – hydromorphone, a licensed pain medication.
New research shows that about 50 per cent of British Columbians with depression are not receiving even the most basic level of care. Authors say the findings highlight the challenges of accessing mental health services across Canada.
The results of the SALOME trial show chronic heroin addiction now has another effective treatment tool – hyrdomorphone, a licensed pain medication.
CHÉOS Scientist Dr. Adeera Levin is co-leading the five-year initiative to improve care for kidney disease, which affects one in ten Canadians.
A new study by The Cedar Project is the first in Canada to show that survivors of sexual abuse and children of residential school survivors are at disproportionately higher risk of sexual assault.